|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,079,680 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,387 |
|
|
Total
Value |
$65,018,530 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
852 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 17 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-03-03 |
4 |
D |
$89.57 |
$805,145 |
D/D |
(8,989) |
331,511 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
60,710 |
392,221 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2016-03-31 |
4 |
A |
$72.47 |
$14,494 |
D/D |
200 |
591 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-04-05 |
4 |
OE |
$14.39 |
$21,585 |
D/D |
1,500 |
393,721 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-04-06 |
4 |
OE |
$14.39 |
$21,585 |
D/D |
1,500 |
395,221 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-04-29 |
4 |
A |
$51.26 |
$21,223 |
D/D |
414 |
395,635 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-05-02 |
4 |
OE |
$12.99 |
$474,135 |
D/D |
36,500 |
432,135 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-05-02 |
4 |
AS |
$85.01 |
$3,102,931 |
D/D |
(36,500) |
395,635 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-05-05 |
4 |
AS |
$80.15 |
$4,007,445 |
I/I |
(50,000) |
0 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-05-05 |
4 |
OE |
$12.99 |
$779,400 |
I/I |
60,000 |
20,000 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-05-05 |
4 |
OE |
$80.15 |
$801,489 |
I/I |
10,000 |
0 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-05-06 |
4 |
D |
$80.80 |
$442,703 |
D/D |
(5,479) |
390,156 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-05-13 |
4 |
D |
$82.71 |
$407,926 |
D/D |
(4,932) |
385,224 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-06-03 |
4 |
D |
$90.00 |
$597,600 |
D/D |
(6,640) |
378,584 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-06-16 |
4 |
OE |
$17.54 |
$730,822 |
D/D |
41,666 |
420,250 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-06-16 |
4 |
AS |
$80.55 |
$3,356,196 |
D/D |
(41,666) |
378,584 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2016-06-30 |
4 |
A |
$79.98 |
$14,476 |
D/D |
181 |
772 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-07-18 |
4 |
OE |
$17.54 |
$730,822 |
D/D |
41,666 |
420,250 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-07-18 |
4 |
AS |
$92.72 |
$3,863,272 |
D/D |
(41,666) |
378,584 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-08-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
400 |
378,184 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-08-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
377,684 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-08-16 |
4 |
OE |
$17.54 |
$730,822 |
D/D |
41,666 |
420,250 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-08-16 |
4 |
AS |
$91.49 |
$3,811,868 |
D/D |
(41,666) |
378,584 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-08-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
200 |
377,484 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-09-15 |
4 |
AS |
$94.85 |
$4,038,360 |
D/D |
(42,577) |
378,584 |
0 |
- |
|
852 Records found
|
|
Page 17 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|